Assessing antibody stability in biological matrices is crucial for ensuring therapeutic efficacy and safety, as degradation can alter pharmacological behavior and compromise product performance. Creative Biolabs' Stability Investigation Services for Antibody in Biological Matrices provide comprehensive evaluation across diverse environments, including serum, plasma, and tissue, delivering actionable insights into physical and chemical degradation pathways. Leveraging over 20 years of expertise, we combine cutting-edge technologies, such as high-resolution LC-MS and SEC-HPLC, with rigorous methodologies including internal standards and high-throughput workflows to ensure exceptional accuracy, reproducibility, and regulatory compliance. Ultimately, our service enables you to de-risk development, accelerate candidate selection, and advance robust antibody-based therapeutics with confidence.
The primary objective of assessing antibody stability in biological matrices is to verify that sample handling, preparation, and storage procedures do not adversely affect the accuracy of its detection and quantification. Degradation of antibodies in environments such as serum or tissue can induce aggregation and fragmentation, thereby modifying their pharmacological behavior. This instability may diminish therapeutic efficacy, potentially elicit immunogenic responses, or influence clearance kinetics. Therefore, a thorough evaluation of antibody stability is critical for establishing robust dose-response relationships and validating bioanalytical methods in both preclinical and clinical studies.
Fig.1 Analytical strategies for assessing antibody stability and functional integrity.1
Creative Biolabs provides comprehensive stability investigation services for antibody in biological matrices which are tailored to the specific biological matrix relevant to the study. Our approach to antibody stability testing is rooted in precision and regulatory compliance, ensuring that every project meets and exceeds industry standards. Our robust methodology, which incorporates internal standards (ISs), provides a significant advantage over conventional methods.
Creative Biolabs offers a comprehensive multi-matrix platform for antibody stability assessment, encompassing the following key categories:
Serum contains high levels of endogenous proteins and proteases that challenge antibody stability.
Antibodies are spiked into serum, incubated under realistic conditions, and protected with protease inhibitors.
Integrity and function are assessed via ELISA, LC-MS, and SEC to detect aggregation, fragmentation, and activity loss.
Plasma requires careful handling due to the presence of anticoagulants (e.g., EDTA, citrate)
Include bench-top, freeze-thaw, and long-term storage stability under varied conditions.
Employs the same rigorous techniques as serum testing to evaluate stability.
Tissue matrices contain diverse proteases and require homogenization, complicating stability analysis.
Include Western Blot for target engagement confirmation, LC-MS for fragmentation profiling, and Thermofluor for thermal stability assessment of extracted antibodies.
Our service workflow is designed for efficiency and precision, following a clear, step-by-step process:
Fig1
The incorporation of internal standards minimizes variability from sample processing and instrument performance, ensuring highly confident and reproducible results.
Our service delivers a comprehensive profile of antibody stability, encompassing both physical degradation (e.g., aggregation and fragmentation) and chemical modifications (such as deamidation and oxidation).
Leveraging advanced automation and analytical platforms, we efficiently process and analyze large sample sets, supporting rapid screening and candidate selection during early development stages.
Our experienced scientists offer end-to-end expert scientific support, spanning study design, execution, and data interpretation to ensure actionable and reliable outcomes.
Long-term stability testing is conducted at the recommended storage conditions to establish a product's shelf life based on real-time data. Accelerated stability testing uses elevated stress conditions to predict a product's stability and evaluate the effects of short-term excursions during shipping and handling.
Biological matrices like serum and tissue contain active proteases that can cleave and degrade antibodies. Adding protease inhibitors prevents this enzymatic degradation, ensuring that any observed instability is due to the inherent properties of the antibody rather than external enzymatic activity.
Creative Biolabs brings together deep expertise, cutting-edge technology, and extensive experience in antibody stability assessment to deliver services that stand out in precision and reliability. Our service offers comprehensive stability profiling across diverse biological matrices including serum, plasma, and tissue, evaluating key degradation pathways such as aggregation, fragmentation, deamidation, and oxidation and helping you make confident decisions in complex biotherapeutic environments.
How to contact us?
To learn more about how Creative Biolabs can support your biopharmaceutical development program with our industry-leading antibody stability testing services, please contact our specialists today.
Reference
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
